Oncology & Hematology Coding Alert

Clinch E/M + Chemo Pay Using These CMS Guidelines

Here's why 99211 flashes a bright red 'audit me' sign at payers. At roughly $60 a pop, missing just one 99213 service a day could cost your practice more than $15,000 a year. Use these official rules from Medicare to be sure you know when you should -- and shouldn't -- add an E/M code to your therapeutic drug and chemotherapy administration claims. Nip 99211-Based Denials in the Bud Medicare will not pay 99211 (Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician. Usually, the presenting problem[s] are minimal. Typically, 5 minutes are spent performing or supervising these services) separately when you report it alongside the following: • Chemotherapy or nonchemotherapy drug administration • Diagnostic or therapeutic drug injection. The Medicare Claims Processing Manual (MCPM), Chapter 12, Section 30.6.7.D spells this rule out for you (www.cms.hhs.gov/Manuals/IOM/list.asp). The [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All